Possible therapeutic role of a highly standardized mixture of active compounds derived from cultured Lentinula edodes mycelia (AHCC) in patients infected with 2019 novel coronavirus.
Identifieur interne : 000455 ( PubMed/Checkpoint ); précédent : 000454; suivant : 000456Possible therapeutic role of a highly standardized mixture of active compounds derived from cultured Lentinula edodes mycelia (AHCC) in patients infected with 2019 novel coronavirus.
Auteurs : Francesco Di Pierro [Oman] ; Alexander Bertuccioli [Italie] ; Ilaria Cavecchia [Italie]Source :
- Minerva gastroenterologica e dietologica [ 1827-1642 ] ; 2020.
Abstract
The outbreak of SARS-CoV-2 disease (COVID-19) is currently, March 2020, affecting more than 100000 people worldwide and, according to the WHO (World Health Organization), a pandemic is shortly expected. The virus infects the lower respiratory tract and causes severe pneumonia and mortality in approximately 10% and 3-5%, respectively, of cases, mainly among the elderly and/or people affected by other diseases. AHCC is an α-glucan-based standardized mushroom extract that has been extensively investigated as an immunostimulant both in animals and/or in humans affected by West Nile virus, influenza virus, avian influenza virus, hepatitis C virus, papillomavirus, herpes virus, hepatitis B virus and HIV by promoting a regulated and protective immune response. Although the efficacy of AHCC has not yet been specifically evaluated with respect to SARS-CoV-2 disease, its action in promoting a protective response to a wide range of viral infections, and the current absence of effective vaccines, could support its use in the prevention of diseases provoked by human pathogenic coronavirus, including COVID-19.
DOI: 10.23736/S1121-421X.20.02697-5
PubMed: 32162896
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:32162896Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Possible therapeutic role of a highly standardized mixture of active compounds derived from cultured Lentinula edodes mycelia (AHCC) in patients infected with 2019 novel coronavirus.</title><author><name sortKey="Di Pierro, Francesco" sort="Di Pierro, Francesco" uniqKey="Di Pierro F" first="Francesco" last="Di Pierro">Francesco Di Pierro</name><affiliation wicri:level="3"><nlm:affiliation>Scientific & Research Department, Velleja Research, Milan, Italy - f.dipierro@vellejaresearch.com.</nlm:affiliation><country wicri:rule="url">Oman</country><wicri:regionArea>Scientific & Research Department, Velleja Research, Milan</wicri:regionArea><placeName><settlement type="city">Milan</settlement><region nuts="2">Lombardie</region></placeName></affiliation></author><author><name sortKey="Bertuccioli, Alexander" sort="Bertuccioli, Alexander" uniqKey="Bertuccioli A" first="Alexander" last="Bertuccioli">Alexander Bertuccioli</name><affiliation wicri:level="1"><nlm:affiliation>D.I.S.B., Urbino, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>D.I.S.B., Urbino</wicri:regionArea><wicri:noRegion>Urbino</wicri:noRegion></affiliation></author><author><name sortKey="Cavecchia, Ilaria" sort="Cavecchia, Ilaria" uniqKey="Cavecchia I" first="Ilaria" last="Cavecchia">Ilaria Cavecchia</name><affiliation wicri:level="3"><nlm:affiliation>Scientific & Research Department, Velleja Research, Milan, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Scientific & Research Department, Velleja Research, Milan</wicri:regionArea><placeName><settlement type="city">Milan</settlement><region nuts="2">Lombardie</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32162896</idno><idno type="pmid">32162896</idno><idno type="doi">10.23736/S1121-421X.20.02697-5</idno><idno type="wicri:Area/PubMed/Corpus">000614</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000614</idno><idno type="wicri:Area/PubMed/Curation">000614</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000614</idno><idno type="wicri:Area/PubMed/Checkpoint">000455</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000455</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Possible therapeutic role of a highly standardized mixture of active compounds derived from cultured Lentinula edodes mycelia (AHCC) in patients infected with 2019 novel coronavirus.</title><author><name sortKey="Di Pierro, Francesco" sort="Di Pierro, Francesco" uniqKey="Di Pierro F" first="Francesco" last="Di Pierro">Francesco Di Pierro</name><affiliation wicri:level="3"><nlm:affiliation>Scientific & Research Department, Velleja Research, Milan, Italy - f.dipierro@vellejaresearch.com.</nlm:affiliation><country wicri:rule="url">Oman</country><wicri:regionArea>Scientific & Research Department, Velleja Research, Milan</wicri:regionArea><placeName><settlement type="city">Milan</settlement><region nuts="2">Lombardie</region></placeName></affiliation></author><author><name sortKey="Bertuccioli, Alexander" sort="Bertuccioli, Alexander" uniqKey="Bertuccioli A" first="Alexander" last="Bertuccioli">Alexander Bertuccioli</name><affiliation wicri:level="1"><nlm:affiliation>D.I.S.B., Urbino, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>D.I.S.B., Urbino</wicri:regionArea><wicri:noRegion>Urbino</wicri:noRegion></affiliation></author><author><name sortKey="Cavecchia, Ilaria" sort="Cavecchia, Ilaria" uniqKey="Cavecchia I" first="Ilaria" last="Cavecchia">Ilaria Cavecchia</name><affiliation wicri:level="3"><nlm:affiliation>Scientific & Research Department, Velleja Research, Milan, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Scientific & Research Department, Velleja Research, Milan</wicri:regionArea><placeName><settlement type="city">Milan</settlement><region nuts="2">Lombardie</region></placeName></affiliation></author></analytic><series><title level="j">Minerva gastroenterologica e dietologica</title><idno type="eISSN">1827-1642</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The outbreak of SARS-CoV-2 disease (COVID-19) is currently, March 2020, affecting more than 100000 people worldwide and, according to the WHO (World Health Organization), a pandemic is shortly expected. The virus infects the lower respiratory tract and causes severe pneumonia and mortality in approximately 10% and 3-5%, respectively, of cases, mainly among the elderly and/or people affected by other diseases. AHCC is an α-glucan-based standardized mushroom extract that has been extensively investigated as an immunostimulant both in animals and/or in humans affected by West Nile virus, influenza virus, avian influenza virus, hepatitis C virus, papillomavirus, herpes virus, hepatitis B virus and HIV by promoting a regulated and protective immune response. Although the efficacy of AHCC has not yet been specifically evaluated with respect to SARS-CoV-2 disease, its action in promoting a protective response to a wide range of viral infections, and the current absence of effective vaccines, could support its use in the prevention of diseases provoked by human pathogenic coronavirus, including COVID-19.</div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32162896</PMID><DateRevised><Year>2020</Year><Month>03</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1827-1642</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year><Month>Mar</Month><Day>12</Day></PubDate></JournalIssue><Title>Minerva gastroenterologica e dietologica</Title><ISOAbbreviation>Minerva Gastroenterol Dietol</ISOAbbreviation></Journal><ArticleTitle>Possible therapeutic role of a highly standardized mixture of active compounds derived from cultured Lentinula edodes mycelia (AHCC) in patients infected with 2019 novel coronavirus.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.23736/S1121-421X.20.02697-5</ELocationID><Abstract><AbstractText>The outbreak of SARS-CoV-2 disease (COVID-19) is currently, March 2020, affecting more than 100000 people worldwide and, according to the WHO (World Health Organization), a pandemic is shortly expected. The virus infects the lower respiratory tract and causes severe pneumonia and mortality in approximately 10% and 3-5%, respectively, of cases, mainly among the elderly and/or people affected by other diseases. AHCC is an α-glucan-based standardized mushroom extract that has been extensively investigated as an immunostimulant both in animals and/or in humans affected by West Nile virus, influenza virus, avian influenza virus, hepatitis C virus, papillomavirus, herpes virus, hepatitis B virus and HIV by promoting a regulated and protective immune response. Although the efficacy of AHCC has not yet been specifically evaluated with respect to SARS-CoV-2 disease, its action in promoting a protective response to a wide range of viral infections, and the current absence of effective vaccines, could support its use in the prevention of diseases provoked by human pathogenic coronavirus, including COVID-19.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Di Pierro</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Scientific & Research Department, Velleja Research, Milan, Italy - f.dipierro@vellejaresearch.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertuccioli</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>D.I.S.B., Urbino, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cavecchia</LastName><ForeName>Ilaria</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Scientific & Research Department, Velleja Research, Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Minerva Gastroenterol Dietol</MedlineTA><NlmUniqueID>9109791</NlmUniqueID><ISSNLinking>1121-421X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32162896</ArticleId><ArticleId IdType="pii">S1121-421X.20.02697-5</ArticleId><ArticleId IdType="doi">10.23736/S1121-421X.20.02697-5</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Italie</li><li>Oman</li></country><region><li>Lombardie</li></region><settlement><li>Milan</li></settlement></list><tree><country name="Oman"><region name="Lombardie"><name sortKey="Di Pierro, Francesco" sort="Di Pierro, Francesco" uniqKey="Di Pierro F" first="Francesco" last="Di Pierro">Francesco Di Pierro</name></region></country><country name="Italie"><noRegion><name sortKey="Bertuccioli, Alexander" sort="Bertuccioli, Alexander" uniqKey="Bertuccioli A" first="Alexander" last="Bertuccioli">Alexander Bertuccioli</name></noRegion><name sortKey="Cavecchia, Ilaria" sort="Cavecchia, Ilaria" uniqKey="Cavecchia I" first="Ilaria" last="Cavecchia">Ilaria Cavecchia</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000455 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000455 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= CovidV2
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:32162896
|texte= Possible therapeutic role of a highly standardized mixture of active compounds derived from cultured Lentinula edodes mycelia (AHCC) in patients infected with 2019 novel coronavirus.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:32162896" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a CovidV2
| This area was generated with Dilib version V0.6.33. |  |